NR 507 Week 1 Discussion; Human Immunodeficiency Virus (HIV)
Document Preview
Unlock Full 3 Page Document Instantly.
Document Overview
candidiasis (thrush), an opportunistic fungal infection. HIV-related depletion of CD4+ T cells impairs mucosal immunity, allowing Candida species to proliferate. Oral thrush is a standard early indicator of significant immune compromise in HIV (CDC, 2023). • “Been sick a lot lately” Recurrent or frequent illnesses reflect progressive immune dysfunction caused by declining CD4 counts and chronic immune activation. As HIV advances, patients become increasingly susceptible to recurrent bacterial, viral, and fungal infections that would otherwise be controlled by a healthy immune system (Bekker et al., 2023). b. Analyze Wilbur’s clinical manifestations as they relate to your assigned disease process (HIV). Do these findings support your assigned disease process? Why or why not? Wilbur’s clinical manifestations are highly supportive of HIV as the assigned disease process. The combination of a painless purple rash suggestive of Kaposi sarcoma, oral candidiasis, and recurrent illness reflects advanced immune suppression consistent with untreated HIV infection. These findings collectively make HIV a firm and likely diagnosis, warranting prompt diagnostic testing and intervention. Kaposi sarcoma is caused by human herpesvirus-8 (HHV-8) and typically occurs in individuals with significant immune suppression due to HIV. Its presence suggests a markedly reduced CD4 count and supports the likelihood of advanced HIV disease rather than a benign dermatologic condition (NIH, 2023). Oral thrush occurs when decreased cell-mediated immunity allows overgrowth of Candida species and is often an early clinical marker of immune compromise in individuals with HIV (CDC, 2023). Additionally, Wilbur’s report that he has “been sick a lot lately” further supports HIV as the underlying disease process. Recurrent or frequent infections are a hallmark of progressive HIV infection and reflect impaired immune surveillance and reduced ability to fight common pathogens. c. Identify and justify the diagnostic tests (including labs, imaging, or other diagnostic tests) that may be most appropriate for investigating your assigned disease process (HIV) as the diagnosis for Wilbur. Discuss anticipated test results. The most appropriate initial test is the fourth-generation HIV-1/2 antigen–antibody combination immunoassay. This test detects both HIV-1/2 antibodies and the p24 antigen, allowing for earlier and more accurate diagnosis than antibody-only tests. If the screening test is reactive, it should be followed by an HIV-1/HIV-2 differentiation immunoassay to confirm infection and identify the virus type (CDC, 2023). Given Wilbur’s symptoms, the screening test would likely be reactive, with confirmatory testing identifying HIV-1 infection. An HIV
Full content available after purchase or with an active subscription.
Related Products
Related Products
NR 507 Week 1 Assignment; Immune Response
NR 507 Week 1 Discussion; Allergies and Immunocompromised States
NR 507 Week 1 Discussion; Immune System Dysfunction & Rash Analysis
NR 507 Week 1 Discussion; Immunity; Hypersensitivity-Immunodeficiency
NR 507 Week 1 Discussion; Introductions (not graded, but required)
NR 507 Week 1 Discussion; Introductions (not graded, but required) & Summary
NR 507 Week 1 Discussion; Pathophysiology and Clinical Aspects of HIV
NR 507 Week 1 Edapt Practice Questions; Hypersensitivity, anemias, immunodeficiency.
NR 507 Week 1 Edapt; Anemias & hemoglobinopathies
NR 507 Week 1 Edapt; Hypersensitivity
NR 507 Week 1 Edapt; Introduction to Anemia
NR 507 Week 1-3 Edapt; Questions and Materials
NR 507 Week 2 Assignment; Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological and Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological Disorders
NR 507 Week 2 Clinical Reasoning Webinar Transcript
NR 507 Week 2 Discussion; Amyotrophic Lateral Sclerosis (ALS)
NR 507 Week 2 Discussion; Choose Your Own Pathophysiology Adventure, Part 1 of 3
NR 507 Week 2 Discussion; Chronic Obstructive Pulmonary Disease
NR 507 Week 2 Edapt Practice Questions; Cardiovascular and Hematology Disorders
NR 507 Week 2 Edapt; Cardio & Hematologic Components; Key Points & Final Review
NR 507 Week 2 Edapt; Cardiovascular and hematology disorders - Practice Questions-Answers
NR 507 Week 2 Edapt; Cardiovascular Disorders
NR 507 Week 2 Edapt; Hematology
NR 507 Week 2 Edapt; Study Guide Anemia
NR 507 Week 3 Assignment; Alterations in Pulmonary Function
NR 507 Week 3 Assignment; Alterations in Pulmonary Function.
NR 507 Week 3 Discussion
NR 507 Week 3 Discussion; Anemia and Its Implications
NR 507 Week 3 Discussion; Heart failure (HF)
NR 507 Week 3 Discussion; Pathophysiology of Anemia and Asthma
NR 507 Week 3 Edapt Practice Questions; Respiratory System
NR 507 Week 3 Edapt; Obstructive and Restrictive Lung Diseases
NR 507 Week 3 Edapt; Respiratory System - Practice Questions-Answers
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders.
NR 507 Week 4 Collaboration Cafe; Cardiovascular Involvement in SLE Pathophysiology
NR 507 Week 4 Collaboration Cafe; Urinary System Pathologies
NR 507 Week 4 Edapt Practice Questions; Urinary, Renal System
NR 507 Week 4 Edapt; Urinary System Pathologies
NR 507 Week 4 Midterm Exam Practice Questions-Answers
NR 507 Week 4 Midterm Exam Solved
NR 507 Week 4 Midterm Exam..
NR 507 Week 4 Midterm Practice Exam Questions (Weeks 1-4)
NR 507 Week 4 Midterm Real Past Exam Questions-Answers
NR 507 Week 4-5 Edapt Questions and Material
NR 507 Week 5 Assignment; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3 - Sickle Cell Disease
NR 507 Week 5 Discussion; COPD and Its Implications
NR 507 Week 5 Edapt; Anxiety Disorders
NR 507 Week 5 Edapt; Depression
NR 507 Week 5 Edapt; GERD; Alterations in the Gastrointestinal System
NR 507 Week 5 Edapt; Inflammatory Bowel Disease
NR 507 Week 5 Edapt; Liver Cirrhosis
NR 507 Week 5 Edapt; Mood Disorders
NR 507 Week 5 Edapt; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Edapt; Peptic Ulcer Disease
NR 507 Week 5 Edapt; Schizophrenia, Ch 19, Pg 618
NR 507 Week 5-6 Edapt Content
NR 507 Week 6 Assignment; Alterations in the Endocrine System
NR 507 Week 6 Case Study; Pathophysiology & Clinical Findings of Type 2 Diabetes
NR 507 Week 6 Discussion
NR 507 Week 6 Discussion; Cirrhosis
NR 507 Week 7 Assignment; CNS; Sensory and Motor Disorders
NR 507 Week 7 CNS; Sensory and Motor Disorders
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3 - Heart Failure and Neuropathy
NR 507 Week 7 Edapt Content; CNS Sensory and Motor Disorders
NR 507 Week 8 CNS; Brain Disorders & Dermatological Conditions
NR 507 Week 8 Collaboration Cafe
NR 507 Week 8 Collaborative Cafe
NR 507 Week 8 Edapt Content; CNS Brain Disorders
NR 507 Week 8 Final Exam - Questions-Answers
NR 507 Week 8 Final Exam Compilation
NR 507 Week 8 Final Exam Master Study Guide
NR 507 Week 8 Final Exam Master Study Guide - Answered Bullet-by-Bullet.
NR 507 Week 8 Final Exam Review - Made this for the final and really helped me ace it!
NR 507 Week 8 Final Exam Study Guide Review
NR 507 Week 8 Final Exam..
NR 507 Week 8 Group Final Exam Questions
Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.